Back to search

Article

Risk of Inflammatory Bowel Disease in Psoriasis Patients Treated with Anti-Interleukin-17 Agents: A Bayesian Metaanalysis

2019-11-19

Abstract excerpt

<h4>Background</h4> Use of interleukin-17 inhibitors (IL-17i) in psoriasis has been associated with an increased risk of inflammatory bowel disease (IBD). However, the clinical significance of this association is not understood. <h4>Objectives</h4> To quantify the absolute risk of IBD in patients with psoriasis treated with IL-17i, stratified by known IBD risk factors. <h4>Methods</h4> Literature searches were per...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
df666716-d178-522a-9171-dfdef1b6efd1
DOI
10.1101/19012179
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Risk of Inflammatory Bowel Disease in Psoriasis Patients Treated with Anti-Interleukin-17 Agents: A Bayesian MetaanalysisDOI 10.1101/19012179
Select a neighboring publication to make it the new centre.